1. Tumors of the breast and the female genital organs;FA Tavasolli,2003
2. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER cancer statistics review, 1975–2010, National Cancer Institute, Bethesda
http://seer.cancer.gov/csr/1975_2010/
, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. [database on the Internet]
3. Gurung A, Hung T, Morin J, Gilks CB (2013) Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates. Histopathology 62(1):59–70
4. Prat J, Ribe A, Gallardo A (2005) Hereditary ovarian cancer. Hum Pathol 36(8):861–870
5. Menon U, Griffin M, Gentry-Maharaj A (2014) Ovarian cancer screening – current status, future directions. Gynecol Oncol 132(2):490–495